1. Akula KK, Dhir A, Kulkarni SK. Pro-convulsant effect of cefazolin sodium against pentylenetetrazol- or picrotoxin-induced convulsions in mice. Indian J Exp Biol. 2007; 45:720–725. PMID:
17877149.
2. Arkaravichien W, Tamungklang J, Arkaravichien T. Cefazolin induced seizures in hemodialysis patients. J Med Assoc Thai. 2006; 89:1981–1983. PMID:
17205885.
3. Boswell MV, Wolfe JR. Intrathecal cefazolin-induced seizures following attempted discography. Pain Physician. 2004; 7:103–106. PMID:
16868620.
4. De Sarro A, De Sarro GB, Ascioti C, Nisticó G. Epileptogenic activity of some beta-lactam derivatives : structure-activity relationship. Neuropharmacology. 1989; 28:359–365. PMID:
2747848.
Article
5. De Sarro A, Zappalá M, Chimirri A, Grasso S, De Sarro GB. Quinolones potentiate cefazolin-induced seizures in DBA/2 mice. Antimicrob Agents Chemother. 1993; 37:1497–1503. PMID:
8395790.
Article
6. Gardner P, Leipzig T, Phillips P. Infections of central nervous system shunts. Med Clin North Am. 1985; 69:297–314. PMID:
3990436.
Article
7. Höffler D, Demers HG, Niemeyer R. [Neurotoxicity of modern cephalosporins]. Dtsch Med Wochenschr. 1986; 111:197–198. PMID:
3943473.
8. James HE, Walsh JW, Wilson HD, Connor JD, Bean JR, Tibbs PA. Prospective randomized study of therapy in cerebrospinal fluid shunt infection. Neurosurgery. 1980; 7:459–463. PMID:
7003434.
Article
9. Kamei C, Sunami A, Tasaka K. Epileptogenic activity of cephalosporins in rats and their structure-activity relationship. Epilepsia. 1983; 24:431–439. PMID:
6873002.
Article
10. Lee Y, Pyun SB, Park EK, Youn SW. Persistent dysarthria after cefazolin-induced status epilepticus. Brain Inj. 2009; 23:846–851. PMID:
19697174.
Article
11. Lin CS, Cheng CJ, Chou CH, Lin SH. Piperacillin/tazobactam-induced seizure rapidly reversed by high flux hemodialysis in a patient on peritoneal dialysis. Am J Med Sci. 2007; 333:181–184. PMID:
17496739.
Article
12. Manzella JP, Paul RL, Butler IL. CNS toxicity associated with intraventricular injection of cefazolin. Report of three cases. J Neurosurg. 1988; 68:970–971. PMID:
3373292.
13. Martin ES 3rd, Bagwell JT, Bush-Veith S, Renger H Jr. Seizures after intraventricular cefazolin administration. Clin Pharm. 1992; 11:104–105. PMID:
1551295.
14. McLaurin RL. Treatment of infected ventricular shunts. Childs Brain. 1975; 1:306–310. PMID:
1175443.
Article
15. Michenfelder JD, Cucchiara RF, Sundt TM Jr. Influence of intraoperative antibiotic choice on the incidence of early postcraniotomy seizures. J Neurosurg. 1990; 72:703–705. PMID:
2324795.
Article
16. Nisticò G, De Sarro GB, Naccari F, Musolino R, Rotiroti D, Gallitto G, et al. Cefazolin : a valid model of experimental epilepsy? Monogr Neural Sci. 1980; 5:14–19. PMID:
7322147.
17. Park KS, Lee YW. The effect of topical application of antibiotics on the cerebral cortex. J Korean Neurosurg Soc. 1981; 10:39–52.
18. Schliamser SE, Cars O, Norrby SR. Neurotoxicity of beta-lactam antibiotics : predisposing factors and pathogenesis. J Antimicrob Chemother. 1991; 27:405–425. PMID:
1856121.
Article
19. Wald SL, McLaurin RL. Cerebrospinal fluid antibiotic levels during treatment of shunt infections. J Neurosurg. 1980; 52:41–46. PMID:
7350279.
Article
20. Yost RL, Lee JD, O'Leary JP. Convulsions associated with sodium cefazolin : a case report. Am Surg. 1977; 43:417–420. PMID:
869336.
21. Yu QH, Kitazumi K, Kamei C, Tasaka K. Epileptogenic activity induced by intravenous injection of certain cephalosporins in rats. J Pharmacobiodyn. 1984; 7:586–592. PMID:
6512680.
Article